Results 121 to 130 of about 40,178 (286)

PUVA-induced Bullous Pemphigoid in Psoriasis [PDF]

open access: yes, 2016
The association between psoriasis vulgaris and bullous pemphigoid is due to the still unclear autoimmune process. The common place of action is dermo-epidermal junction or basal membrane zone (BMZ) with specific alterations for both diseases ...
V'lckova Laskoska, Marija   +2 more
core   +1 more source

Evaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross‐Sectional Study

open access: yesHealth Science Reports
Background and Aim Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients
Zeinab Aryanian   +7 more
doaj   +1 more source

Psoriasis vulgaris, bullous pemphigoid, metabolic syndrome – coincidence or common pathogenetic background? Case report

open access: yes, 2014
Introduction. The correlation between psoriasis and metabolic syndrome has been well established. Psoriasis may also coexist with autoimmune blistering disease, mainly bullous pemphigoid.
Anna Leśniewska   +4 more
core   +1 more source

Mast Cells in Host Defense Against Cutaneous Staphylococcus aureus Infection

open access: yesImmunology &Cell Biology, EarlyView.
Impact of S. aureus epicutaneous sensitization models on mast cell function in vivo. D. farinae and Staphylococcal enterotoxin B (SEB) activate Trpv1+ Tac1+ nociceptors to trigger the release of substance P (SP), which promotes mast cell degranulation through Mrgprb2. S.
Hannah Dychtenberg   +3 more
wiley   +1 more source

Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nina Matthes   +6 more
wiley   +1 more source

Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

open access: yesImmunology, EarlyView.
PSTPIP2 acts as a key brake on myeloid inflammation by suppressing IL‐1β‐driven signalling, macrophage dysregulation and inflammation‐associated bone remodelling. Its emerging roles in CRMO/CMO, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid support its potential as a biomarker and therapeutic target.
Erdong Zhang   +9 more
wiley   +1 more source

Bullous larva migrans

open access: yes, 1999
Cutaneous larva migrans is characterized clinically by slightly raised tracks: they are erythematous, linear or serpiginous, sometimes ramified and intertwined, of variable length and width.
F. Zorzi   +3 more
core   +2 more sources

Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran

open access: yesActa Medica Iranica, 2018
Bullous Pemphigoid is a chronic immunobullous disease, characterized by subepidermal bulla on the skin and mucosa. The purpose of the present study was to investigate the clinicoepidemiological features of bullous pemphigoid in Iranian patients.
Kamran Balighi   +5 more
doaj  

Management of Non‐Plaque‐Induced Gingival Conditions: A Systematic Review—Part 2: Inflammatory and Immune Conditions; Neoplasms; and Gingival Pigmentation

open access: yesJournal of Clinical Periodontology, EarlyView.
ABSTRACT Aims This systematic review assesses current evidence on the management of non‐plaque (dental biofilm)‐induced gingival diseases and conditions (NPIGDs), including (i) inflammatory and immune conditions, (ii) neoplasms and (iii) gingival pigmentations.
Maria Clotilde Carra   +5 more
wiley   +1 more source

Milia en plaque – therapeutic response to calcipotriol

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Veronika Hall, Johannes M. Weiss
wiley   +1 more source

Home - About - Disclaimer - Privacy